Clinical Course and Flow Cytometric Analysis of Paroxysmal Nocturnal Hemoglobinuria in the United States and Japan
Top Cited Papers
- 1 May 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 83 (3), 193-207
- https://doi.org/10.1097/01.md.0000126763.68170.46
Abstract
To determine and directly compare the clinical course of white and Asian patients with paroxysmal nocturnal hemoglobinuria (PNH), data were collected for epidemiologic analysis on 176 patients from Duke University and 209 patients from Japan. White patients were younger with significantly more classical symptoms of PNH including thrombosis, hemoglobinuria, and infection, while Asian patients were older with more marrow aplasia. The mean fraction of CD59-negative polymorphonuclear cells (PMN) at initial analysis was higher among Duke patients than Japanese patients. In both cohorts, however, a larger PNH clone was associated with classical PNH symptoms, while a smaller PNH clone was associated with marrow aplasia. Thrombosis was significantly more prevalent in white patients than Asian patients, and was associated with a significantly higher proportion of CD59-negative PMN. For individual patients, CD59-negative populations varied considerably over time, but a decreasing PNH clone portended hematopoietic failure. Survival analysis revealed a similar death rate in each group, although causes of death were different and significantly more Duke patients died from thrombosis. Japanese patients had a longer mean survival time (32.1 yr vs. 19.4 yr), although Kaplan-Meier survival curves were not significantly different. Poor survival in both groups was associated with age over 50 years, severe leukopenia/neutropenia at diagnosis, and severe infection as a complication; additionally, thrombosis at diagnosis or follow-up for Duke patients and renal failure for Japanese patients were poor prognostic factors. These data identify important differences between white and Asian patients with PNH. Identification of prognostic factors will help the design of prospective clinical trials for PNH.Keywords
This publication has 44 references indexed in Scilit:
- A SIN lentiviral vector containing piga cdna allows long-term phenotypic correction of CD34+-derived cells from patients with paroxysmal nocturnal hemoglobinuriaMolecular Therapy, 2003
- Efficient retrovirus-mediated PIG-A gene transfer and stable restoration of GPI-anchored protein expression in cells with the PNH phenotypeBlood, 2001
- Successful unrelated donor bone marrow transplantation for paroxysmal nocturnal hemoglobinuriaBone Marrow Transplantation, 2001
- Bone marrow transplants for paroxysmal nocturnal haemoglobinuriaBritish Journal of Haematology, 1999
- The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuriaBritish Journal of Haematology, 1995
- Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypLc analysis of erythrocytes using two‐colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIFBritish Journal of Haematology, 1993
- The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysisBritish Journal of Haematology, 1991
- Heterogenous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytesBritish Journal of Haematology, 1991
- Paroxysmal Nocturnal Haemoglobinuria in Thailand with Special Reference to an Association with Aplastic AnaemiaBritish Journal of Haematology, 1978
- Thrombin Generation in Paroxysmal Nocturnal HaemoglobinuriaBritish Journal of Haematology, 1963